tirzepatide and dental work What are the current recommendations for holding Zepbound (tirzepatide) on the day of a extraction? New Weight Loss Medical Advances.

When Switching Makes Sense and When It Doesnt Switching to tirzepatide may be a good option if: Weight loss has stalled despite consistency Side effects are limiting progress Appetite control remains a challenge Staying on semaglutide may make sense if: Weight loss is steady Side effects are minimal The current dose is working well The right choice depends on how your body is responding, not on comparisons alone

Hauptman JB, Jeunet FS, Hartmann D

These may include financial losses, such as medical expenses and lost income, or personal losses, such as pain and suffering or diminished quality of life

In the Phase 2 retatrutide trial published in the New England Journal of Medicine (2023), participants at the highest dose (12 mg) achieved a mean body weight reduction of approximately 24.2% over 48 weeks

I wasn't even expecting this added bonus but it's SO NICE

In late April 2022, Eli Lilly released preliminary results from the SURMOUNT-1 trial that included overweight and obese patients using tirzepatide who did not have diabetes